Chemoinformaics analysis of (Z)-P-Mentha-2,8-Dien-1-Ol
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -1.736 | nHRing | 0 |
| Solubility: LogP | 2.365 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.571 |
| Synth | 4.127 |
| Natural Product Likeliness | 3.573 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.231 |
| MDCK | 0.0000259 |
| BBB | 0.998 |
| PPB | 0.494655 |
| VDSS | 1.191 |
| FU | 0.485842 |
| CYP1A2-inh | 0.064 |
| CYP1A2-sub | 0.818 |
| CYP2c19-inh | 0.097 |
| CYP2c19-sub | 0.853 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.375 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.583 |
| CYP3a4-inh | 0.313 |
| CYP3a4-sub | 0.356 |
| CL | 8.349 |
| T12 | 0.514 |
| hERG | 0.01 |
| Ames | 0.011 |
| ROA | 0.034 |
| SkinSen | 0.039 |
| Carcinogencity | 0.673 |
| EI | 0.823 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.91633 |